1 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Bupropion 150 mg: new trials by email Literature Review of Bupropion 150 mg trials Research Report on Bupropion 150 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk Bupropion 150 mg, Lyophilized powder from edible mushrooms, Lifestyle Management - Cardiometabolic Syndrome, Obesity and Cardiovascular Risk | Phase 3 | Not yet recruiting | Uppsala University | 250 | 2026-10-30 | 2026-09-08 |
| A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects JNJ-54175446 150 mg, JNJ-54175446 600 mg, Midazolam 2 mg - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 16 | 2017-03-14 | 2017-06-08 |
Hyperlipidemias (1) · Hypertension (1) · Metabolic Syndrome (1) · Obesity (1) · Overweight (1) · Prediabetic State (1)
Janssen Research & Development, LLC (1) · Uppsala University (1)
Belgium (1) · Sweden (1)
Jan Eriksson, MD, PhD (1) · Martin Lundqvist, MD, PhD (1)
2016 (1)